ECG vs EBS: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

ECG has stronger fundamentals based on our AI analysis.

ECG
Everus Construction Group, Inc.
STRONG BUY
85%
Confidence
VS
EBS
Emergent BioSolutions Inc.
BUY
72%
Confidence

ECG vs EBS Fundamental Comparison

Metric ECG EBS
Revenue $3.7B $742.9M
Net Income $201.8M $52.6M
Net Margin 5.4% 7.1%
ROE 32.0% 10.1%
ROA 11.7% 4.0%
Current Ratio 1.76x 5.01x
Debt/Equity 0.45x 1.13x
EPS $3.95 $0.93

Green = Better metric | Red = Weaker metric

View Full ECG Analysis →
View Full EBS Analysis →

You Might Also Compare

ECG vs AAPL EBS vs MSFT ECG vs GOOGL EBS vs AMZN

ECG vs EBS: Frequently Asked Questions

Is ECG or EBS a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), ECG has stronger fundamentals. ECG is rated STRONG BUY (85% confidence) while EBS is rated BUY (72% confidence). This is not investment advice.

How does ECG compare to EBS fundamentally?

Everus Construction Group, Inc. has ROE of 32.0% vs Emergent BioSolutions Inc.'s 10.1%. Net margins are 5.4% vs 7.1% respectively.

Which stock pays higher dividends, ECG or EBS?

ECG has a dividend yield of N/A or no dividend while EBS has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in ECG or EBS for long term?

For long-term investing, consider that ECG has STRONG BUY rating with 85% confidence, while EBS has BUY rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about ECG vs EBS?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ECG vs EBS, the AI consensus favors ECG based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.